Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Meristem Therapeutics

Corn seed-derived dog gastric lipase is under development by Meristem Therapeutics for the treatment of gastric lipase deficiency (steatorrhea), neonatal deficient pancreatic function, or when pancreatic function is compromised by diseases such as cystic fibrosis or chronic alcoholism [159]. The absence of gastric lipase in steatorrhea patients prevents the digestion of food lipids. Pre-term infants have difficulty digesting lipids and, unless they are breast-fed, have no access to this enzyme. [Pg.859]

Meristem Therapeutics http //www.meristem-therapeutics. com Maize, Tobacco... [Pg.904]

Meristem Therapeutics (Clermont-Ferrand, France) has a gastric lipase, produced in grains of corn, for the treatment of cystic fibrosis in Phase II clinical trials. The company also has a recombinant lactoferrin at the stage of preclinical trials, in addition to human serum albumin, collagen and monoclonal antibodies at R D stage. [Pg.905]

Meristem Therapeutics (Clermont-Ferrand, France) Prodigene... [Pg.38]

Meristem Therapeutics Solvay Pharmaceuticals Gastric lipase Corn Phase II... [Pg.41]

Meristem Therapeutics CNRS Human lactoferrin Corn Preclinical... [Pg.41]

See other pages where Meristem Therapeutics is mentioned: [Pg.107]    [Pg.279]    [Pg.881]    [Pg.107]    [Pg.279]    [Pg.881]    [Pg.576]   
See also in sourсe #XX -- [ Pg.128 ]



SEARCH



Meristems

© 2024 chempedia.info